Review
Tovaxin, radiation-attenuated, patient-specific T-cells for the therapeutic vaccination of multiple sclerosis
Affiliations
- PMID: 18465664
Item in Clipboard
Review
Tovaxin, radiation-attenuated, patient-specific T-cells for the therapeutic vaccination of multiple sclerosis
Curr Opin Investig Drugs.
2008 May.
Abstract
Opexa Pharmaceuticals Inc is developing Tovaxin, a trivalent formulation of attenuated myelin-peptide-reactive T-cells, for the potential treatment of multiple sclerosis. Tovaxin is being evaluated in phase II clinical trials. Opexa was previously investigating Tovaxin for the potential treatment of rheumatoid arthritis; however, no development has been reported for this indication since December 2002.
Similar articles
-
Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.J Autoimmun. 1999 Sep;13(2):233-46. doi: 10.1006/jaut.1999.0314. J Autoimmun. 1999. PMID: 10479392
-
Tovaxin for multiple sclerosis.Expert Opin Biol Ther. 2011 Jul;11(7):961-7. doi: 10.1517/14712598.2011.584866. Epub 2011 May 12. Expert Opin Biol Ther. 2011. PMID: 21563876 Review.
-
The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis.Autoimmun Rev. 2010 Feb;9(4):233-6. doi: 10.1016/j.autrev.2009.08.002. Epub 2009 Aug 13. Autoimmun Rev. 2010. PMID: 19683076 Review.
-
T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.Nature. 1990 Jul 12;346(6280):183-7. doi: 10.1038/346183a0. Nature. 1990. PMID: 1694970
-
Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene.J Clin Invest. 2002 Jul;110(1):81-90. doi: 10.1172/JCI15692. J Clin Invest. 2002. PMID: 12093891 Free PMC article.
Cited by
-
The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review.Clin Rev Allergy Immunol. 2014 Oct;47(2):219-33. doi: 10.1007/s12016-014-8439-6. Clin Rev Allergy Immunol. 2014. PMID: 25096807 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical